Breaking News

ViroCell, Great Ormond Street Hospital Partner to Unlock Clinical Trial Backlog

MHRA license will enable global reach of ViroCell’s viral vectors for cell and gene therapy clinical trials.

ViroCell Biologics, a specialist CDMO for cell and gene therapy (CGT) clinical trials, is now able to manufacture and globally export viral vectors from Great Ormond Street Hospital’s (GOSH) state-of-the-art manufacturing facility, the Zayed Centre for Research, for use in clinical trials. This follows the grant of a Manufacturer’s Authorization License (MIA) to GOSH to manufacture viral vectors by the UK’s Medicines and Healthcare products Regulatory Agency’s (MHRA). Viral vectors are common...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters